Lu Hongbo Insider Trades

Insider Trading History

Track insider trading activity for Lu Hongbo. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals ARWR
Director
Holding Value $3.91M 52,012 shares
Last Trade
May 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$228k 2,970 shares
$76.88
$75.16
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $7.84M 426,736 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$70.2k 3,768 shares
$18.63
$18.38
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $7.77M 422,968 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.5M 75,000 shares
$20.00
$18.38
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $6.4M 347,968 shares
Last Trade
Feb 11, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$585k 25,985 shares
$22.50
$18.38
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals ARWR
Director
Holding Value $4.13M 54,982 shares
Last Trade
Dec 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$506k 7,819 shares
$64.66
$75.16
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $5.92M 321,983 shares
Last Trade
Oct 07, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5M 263,160 shares
$19.00
$18.38
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $2.38M 45,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 45,000 shares
$4.10
$52.95
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $340k 18,500 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 18,500 shares
$11.94
$18.38
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $564k 10,657 shares
Last Trade
Feb 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.5k 10,657 shares
$4.46
$52.95
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals ARWR
Director
Holding Value $3.54M 47,163 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 16,733 shares
$22.99
$75.16
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $1.08M 58,823 shares
Last Trade
Sep 13, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$18.38
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $25.2M 476,190 shares
Last Trade
Sep 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.53M 476,190 shares
$9.51
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $248k 4,676 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32k 4,676 shares
$6.85
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $1.69M 32,000 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$224k 32,000 shares
$6.99
$52.95
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals ARWR
Director
Holding Value $2.53M 33,680 shares
Last Trade
Mar 20, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.5k 1,000 shares
$27.50
$75.16
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals ARWR
Director
Holding Value $2.46M 32,680 shares
Last Trade
Mar 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$28k 1,000 shares
$28.00
$75.16
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals ARWR
Director
Holding Value $2.38M 31,680 shares
Last Trade
Mar 18, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.5k 1,000 shares
$27.49
$75.16
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $1.69M 32,000 shares
Last Trade
Jun 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$386k 32,000 shares
$12.05
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $230M 4,340,212 shares
Last Trade
Dec 23, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.26M 758,620 shares
$8.25
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $190M 3,581,592 shares
Last Trade
Sep 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.16M 600,000 shares
$3.60
$52.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up